Cumberland Pharmaceuticals (CPIX) Change in Cash (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Change in Cash of -$437448.0 for Q1 2026, up 88.34% sequentially from -$3.8 million in Q4 2025, and up 84.68% YoY from -$236865.6 in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Change in Cash (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Change in Cash for 17 years, with the latest figure at -$437448.0 in Q1 2026.
- Quarterly Change in Cash rose 84.68% year-over-year to -$437448.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.1 million (down 19.22% YoY) and the FY2025 annual result came in at -$6.5 million, down 1723.94% from the prior year.
- Change in Cash grew to -$437448.0 in Q1 2026 per CPIX's latest filing, from -$3.8 million in the prior quarter.
- Over five years, Change in Cash peaked at $1.9 million in Q2 2023 and troughed at -$9.8 million in Q1 2022.
- A 5-year average of -$943151.2 and a median of $128308.0 in 2024 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 666.9% in 2022, down 5879.04% in 2022.
- Over 5 years, Change in Cash stood at $216432.0 in 2022, then slumped by 186.1% to -$186341.0 in 2023, then surged by 368.02% to $499430.0 in 2024, then plunged by 851.27% to -$3.8 million in 2025, then soared by 88.34% to -$437448.0 in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$437448.0, -$3.8 million, and -$890536.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.71 Mn | 112.84 Mn | - | -7.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.14 Mn |
| Mar 31, 2026 | -437,448.00 |
| Dec 31, 2025 | -3.75 Mn |
| Sep 30, 2025 | -890,536.00 |
| Jun 30, 2025 | 978,868.00 |
| Mar 31, 2025 | -2.86 Mn |
| Dec 31, 2024 | 499,430.00 |
| Sep 30, 2024 | 128,308.00 |
| Jun 30, 2024 | -1.21 Mn |
| Mar 31, 2024 | 226,861.00 |
| Dec 31, 2023 | -186,341.00 |
| Sep 30, 2023 | 258,879.00 |
| Jun 30, 2023 | 1.86 Mn |
| Mar 31, 2023 | -3.37 Mn |
| Dec 31, 2022 | 216,432.00 |
| Sep 30, 2022 | 1.32 Mn |
| Jun 30, 2022 | 949,780.00 |
| Mar 31, 2022 | -9.77 Mn |
| Dec 31, 2021 | 1.20 Mn |
| Sep 30, 2021 | 172,769.00 |